SEPN - Septerna Inc
Septerna, Inc. , a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases. It develops PTH1R Program, oral small molecule Parathyroid Hormone 1 Receptor agonists for the treatment of hypoparathyroidism; SEP-631, an oral small molecule MRGPRX2 negative allosteric modulator (NAM) for chronic spontaneous urticaria and other mast cell diseases; and TSHR Program, an oral small molecule TSHR NAM for graves’ disease and thyroid eye disease.
As of Jun 30, 2026: spot at $32.76, ATM IV 124.1%, max pain $30.00, net GEX $284.4K.
- Sector
- Healthcare
- Industry
- Biotechnology
- Market Cap
- $1.68B
- Beta
- 2.38
- 52-Week Range
- 10.3-37.99
- CEO
- Jeffrey T. Finer
- Employees
- 130
- IPO Date
- Oct 25, 2024
- Exchange
- NASDAQ
What SEPN Looks Like to Options Traders Today
IV rank of 36.7% sits near the 1-year median, where strategy choice depends on directional conviction and the event calendar rather than vol regime alone; positive net gamma exposure ($284.4K) means dealers hedge against trend, damping realized volatility and biasing price toward heavy-OI strikes; the 25-delta skew (0.040) prices calls richer than puts, often reflecting upside speculation or squeeze risk.
What This Page Covers
The SEPN overview links into per-metric analysis views: max pain, gamma exposure, volatility skew, expected move, options chain, open interest history, and aggregate Greeks. Microstructure data is available on short interest, short volume, fail-to-deliver, and market structure. Corporate data is on fundamentals, earnings, analyst ratings, and insider trading.
Frequently asked SEPN overview questions
- What is SEPN?
- SEPN is the ticker symbol for Septerna Inc, a listed security. Septerna, Inc. , a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases. Listed on NASDAQ. SEPN is the equity ticker shown on this page; equity options traders use the security for directional, volatility, and income strategies via the listed options chain.
- What does the SEPN options snapshot look like today?
- As of Jun 30, 2026, the SEPN options snapshot shows spot at $32.76, ATM IV 124.1%, IV rank 36.7%, max pain $30.00, net GEX $284.4K, expected move 35.58%. The full options chain, Greeks by strike and expiration, per-strike open-interest distribution, dealer gamma and delta exposure, and the volatility skew surface are linked from this overview page. Each per-metric route refreshes once per trading session and reflects the most recent close-of-business listed-options state.
- What are SEPN's key statistics?
- Septerna Inc (SEPN) carries a market capitalization of $1.68B, beta of 2.38 relative to the broader market, 52-week range of 10.3-37.99. Full income statement, balance sheet, cash flow, and TTM ratio history is on the per-ticker fundamentals page; daily price history and 52-week levels are accessible from the same view. These structural inputs frame how the options market prices implied volatility around earnings windows and capital events.
- What sector or industry does SEPN belong to?
- Septerna Inc operates in the Healthcare sector, in the Biotechnology industry. Sector classification affects how the ticker correlates with sector ETFs, how it reacts to macro factors like rate moves and commodity prices, and how its options pricing compares to sector peers. Compare SEPN's implied volatility and skew against sector benchmarks to gauge whether the options market is pricing single-name or systemic risk relative to the broader peer group.
- How current is the SEPN data on this page?
- The options snapshot above is dated Jun 30, 2026 and refreshes once per session, with all per-strike Greeks and exposure aggregates recomputed at the daily close. Company-profile fields (sector, industry, market cap, P/E, IPO date) refresh from the vendor feed nightly. Financials and earnings refresh as 10-K and 10-Q filings are parsed (typically within several business days of the actual report). FINRA microstructure data refreshes on the source's cadence (daily for short volume, bi-monthly for short interest, weekly for the OTC volume file, twice-monthly for SEC FTD).